LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.41 | 84.90 | 8738 | 8766 | 0.9968 | 0.9990 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.11 | 84.90 | 847 | 8988 | 0.0942 | 0.4077 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.11 | 84.90 | 9197 | 8988 | 1.0233 | 1.0068 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.11 | 84.90 | 753 | 8988 | 0.0838 | 0.3833 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.11 | 84.90 | 9000 | 8988 | 1.0013 | 1.0004 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.81 | 84.90 | 861 | 9132 | 0.0943 | 0.4095 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.81 | 84.90 | 9513 | 9132 | 1.0417 | 1.0121 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.81 | 84.90 | 950 | 9132 | 0.1040 | 0.4302 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 70.81 | 84.90 | 9205 | 9132 | 1.0080 | 1.0024 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.52 | 84.90 | 848 | 9214 | 0.0920 | 0.4054 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.52 | 84.90 | 9767 | 9214 | 1.0600 | 1.0173 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.52 | 84.90 | 890 | 9214 | 0.0966 | 0.4155 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 72.52 | 84.90 | 9435 | 9214 | 1.0239 | 1.0070 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.22 | 84.90 | 802 | 9343 | 0.0858 | 0.3925 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.22 | 84.90 | 9999 | 9343 | 1.0702 | 1.0201 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.22 | 84.90 | 880 | 9343 | 0.0942 | 0.4117 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.22 | 84.90 | 9557 | 9343 | 1.0229 | 1.0067 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.93 | 84.90 | 871 | 8970 | 0.0971 | 0.4138 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.93 | 84.90 | 10162 | 8970 | 1.1328 | 1.0374 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.93 | 84.90 | 812 | 8970 | 0.0905 | 0.3991 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 75.93 | 84.90 | 9710 | 8970 | 1.0824 | 1.0237 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 77.64 | 84.90 | 999 | 9245 | 0.1081 | 0.4395 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 77.64 | 84.90 | 10399 | 9245 | 1.1247 | 1.0350 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 77.64 | 84.90 | 790 | 9245 | 0.0854 | 0.3905 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 77.64 | 84.90 | 9935 | 9245 | 1.0746 | 1.0214 | MN20160318_Q02 | N15 |